Literature DB >> 28176604

C5 nerve root palsy after posterior cervical spine surgery.

Fu-Min Pan1, Shan-Jin Wang1, Bin Ma1, De-Sheng Wu1.   

Abstract

BACKGROUND: C5 palsy is a serious complication after cervical decompression surgery in which the patient shows a deterioration in power of the deltoid or biceps brachii by at least one grade in the manual muscle test without aggravation of lower extremity function. Although there are several hypotheses regarding the etiology of C5 palsy, the pathogenesis and preventive measures remain unidentified and many other controversies remain.
OBJECTIVE: To systematically review the clinical features, risk factors, mechanism, and preventive measures of C5 palsy after posterior cervical decompression surgery.
MATERIALS AND METHODS: PubMed was searched to identify eligible studies that contained more than 10 cases and focused on C5 palsy. Microsoft Excel was used to analyze the data. Statistical comparisons were made when appropriate.
RESULTS: Out of 718 papers involving C5 palsy, 28 met the inclusion criteria. The average incidence rate was 7.8% (range, 1.4-23.0%). Risk factors for C5 palsy included age, male gender, ossification of the posterior longitudinal ligament, and stenosis of the C4-C5 intervertebral foramen. C5 palsy occurred from immediately to 2 months after surgery, and recovery time ranged from 48 h to 41 months. Hypotheses for the mechanism of C5 palsy included root involvement and spinal cord impairment. Foraminotomy and intraoperative neuromonitoring were the two main methods used to prevent C5 palsy.
CONCLUSION: C5 palsy is a serious complication occurring at the early stage after cervical decompression surgery. Foraminotomy and intraoperative neuromonitoring were the two main methods to prevent C5 palsy. The incidence of C5 palsy is low, but it can place a serious burden on the patients' quality of life and finances. The risk factors and mechanism of C5 palsy are still controversial. However, under conservative therapy, the prognosis is usually good. Higher quality studies are necessary for drawing more reliable and convincing conclusions about this disease.

Entities:  

Keywords:  C5 palsy; cervical spine; laminectomy; laminoplasty; systematic review

Mesh:

Year:  2017        PMID: 28176604     DOI: 10.1177/2309499016684502

Source DB:  PubMed          Journal:  J Orthop Surg (Hong Kong)        ISSN: 1022-5536            Impact factor:   1.118


  5 in total

1.  Is laminectomy and fusion the better choice than laminoplasty for multilevel cervical myelopathy with signal changes on magnetic resonance imaging? A comparison of two posterior surgeries.

Authors:  Xin He; Jia Nan Zhang; Tuan Jiang Liu; Ding Jun Hao
Journal:  BMC Musculoskelet Disord       Date:  2020-07-02       Impact factor: 2.362

2.  Posterior Surgical Techniques for Cervical Spondylotic Myelopathy: WFNS Spine Committee Recommendations.

Authors:  Abdul Hafid Bajamal; Se-Hoon Kim; Mohammad Reza Arifianto; Muhammad Faris; Eko Agus Subagio; Ben Roitberg; Inyang Udo-Inyang; Jonathan Belding; Mehmet Zileli; Jutty K B C Parthiban
Journal:  Neurospine       Date:  2019-09-30

Review 3.  Surgical decision-making for ossification of the posterior longitudinal ligament versus other types of degenerative cervical myelopathy: anterior versus posterior approaches.

Authors:  Suzanna Sum Sum Kwok; Jason Pui Yin Cheung
Journal:  BMC Musculoskelet Disord       Date:  2020-12-08       Impact factor: 2.362

4.  Bridging the cervicothoracic junction during posterior cervical laminectomy and fusion for the treatment of multilevel cervical ossification of the posterior longitudinal ligament: a retrospective case series.

Authors:  Dong-Zhao Wu; Zhen-Fang Gu; De-Jing Meng; Shu-Bing Hou; Liang Ren; Xian-Ze Sun
Journal:  BMC Musculoskelet Disord       Date:  2022-05-12       Impact factor: 2.562

5.  Could Machine Learning Better Predict Postoperative C5 Palsy of Cervical Ossification of the Posterior Longitudinal Ligament?

Authors:  Soo Heon Kim; Sun Ho Lee; Dong Ah Shin
Journal:  Clin Spine Surg       Date:  2022-01-12       Impact factor: 1.723

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.